
- July/August 2013
- Volume 4
- Issue 4
Many Antibody-Positive Patients Are Never HCV RNA Tested
Despite recent guidelines that recommend individuals born from 1945 to 1965 be tested for HCV antibody, and for antibody-positive patients to then receive RNA testing in order to determine infection status, many patients are never tested for HCV RNA, according to the results of a new study published online on June 19, 2013, in the American Journal of Medicine.
Researchers surveyed clinicians of 245 antibody-positive patients newly reported to the New York City Department of Health and Mental Hygiene’s HCV surveillance system. Clinicians of patients who did not undergo RNA testing were asked why the test was not ordered and were requested to order the test.
Approximately 67% of antibody-positive patients were tested for HCV RNA, with 21% of them only receiving the test after the researchers’ request. Despite the request, 33% of patients remained untested. Of those who were not tested, 47% were seen in medical facilities, 30% in detox facilities, and 15% in prison. About 35% of clinicians reported that the test was not administered because the patient did not return for a follow-up, 22% stated that their facility does not do RNA testing, and 15% said the patient was tested in jail.
The authors note that with improved antiviral treatments available for HCV, RNA testing for antibody-positive patients should become routine.
Articles in this issue
over 12 years ago
September-October 2013 Meetingsover 12 years ago
Growth Hormone Therapy: A Specialty Pharmacy Overviewover 12 years ago
HCV and OBI Co-Infections May Increase Poor Outcomesover 12 years ago
RSV Infections in Infancy Linked to Wheezing in Childhoodover 12 years ago
Triple Therapy May Cause More Adverse Reactions in HCV Patientsover 12 years ago
Adding a Specialty Pharmacy to Your Retail Brandover 12 years ago
How Smartphones Will Transform Your Patient Relationshipsover 12 years ago
Who Really Knows Best?over 12 years ago
Distribution Networks: Why Limit Them?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


















































































































































































































